CN103539753B - A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 - Google Patents
A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 Download PDFInfo
- Publication number
- CN103539753B CN103539753B CN201310496481.5A CN201310496481A CN103539753B CN 103539753 B CN103539753 B CN 103539753B CN 201310496481 A CN201310496481 A CN 201310496481A CN 103539753 B CN103539753 B CN 103539753B
- Authority
- CN
- China
- Prior art keywords
- isoxazole
- substitution
- ketone
- reaction
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000006467 substitution reaction Methods 0.000 title claims abstract description 28
- 238000010189 synthetic method Methods 0.000 title claims abstract description 11
- UBNWPQXLFRMMEI-GQCTYLIASA-N 5-[3-[(e)-3-(3-hydroxy-2-methoxycarbonylphenoxy)prop-1-enyl]phenyl]-1,2-oxazole-3-carboxylic acid Chemical compound COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC=CC(C=2ON=C(C=2)C(O)=O)=C1 UBNWPQXLFRMMEI-GQCTYLIASA-N 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 59
- -1 dimethylamino methylene Chemical group 0.000 claims abstract description 28
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002585 base Substances 0.000 claims abstract description 10
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 230000007062 hydrolysis Effects 0.000 claims abstract description 7
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 7
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000000977 initiatory effect Effects 0.000 claims abstract description 4
- 150000002576 ketones Chemical class 0.000 claims abstract description 4
- 150000002596 lactones Chemical class 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 150000005840 aryl radicals Chemical class 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000003851 azoles Chemical class 0.000 claims 1
- QNEFNFIKZWUAEQ-UHFFFAOYSA-N carbonic acid;potassium Chemical compound [K].OC(O)=O QNEFNFIKZWUAEQ-UHFFFAOYSA-N 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 14
- 239000002253 acid Substances 0.000 abstract description 5
- 150000002148 esters Chemical class 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 8
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 235000011167 hydrochloric acid Nutrition 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 150000002240 furans Chemical class 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- SZKVGVRLYVFVFP-UHFFFAOYSA-N 3-phenyl-1,2-oxazole-4-carboxylic acid Chemical class OC(=O)C1=CON=C1C1=CC=CC=C1 SZKVGVRLYVFVFP-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- UORVCLMRJXCDCP-UHFFFAOYSA-M propynoate Chemical compound [O-]C(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-M 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YBLSBWHFPXDRHC-UHFFFAOYSA-N 3-methyl-1,2-oxazole-4-carboxylic acid Chemical class CC1=NOC=C1C(O)=O YBLSBWHFPXDRHC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical class COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310496481.5A CN103539753B (en) | 2013-10-22 | 2013-10-22 | A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310496481.5A CN103539753B (en) | 2013-10-22 | 2013-10-22 | A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103539753A CN103539753A (en) | 2014-01-29 |
CN103539753B true CN103539753B (en) | 2017-06-23 |
Family
ID=49963659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310496481.5A Active CN103539753B (en) | 2013-10-22 | 2013-10-22 | A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103539753B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114716389A (en) * | 2021-12-31 | 2022-07-08 | 北京岳达生物科技有限公司 | Synthetic method of 3, 5-diethylisoxazole-4-carboxylic acid |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040167188A1 (en) * | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
WO2008011453A2 (en) * | 2006-07-20 | 2008-01-24 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
CN102271515A (en) * | 2008-10-31 | 2011-12-07 | 健泰科生物技术公司 | Pyrazolopyrimidine JAK inhibitor compounds and methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002322054A (en) * | 2001-04-26 | 2002-11-08 | Dai Ichi Seiyaku Co Ltd | Drug discharging pump inhibitor |
-
2013
- 2013-10-22 CN CN201310496481.5A patent/CN103539753B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040167188A1 (en) * | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
WO2008011453A2 (en) * | 2006-07-20 | 2008-01-24 | Amgen Inc. | SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
CN102271515A (en) * | 2008-10-31 | 2011-12-07 | 健泰科生物技术公司 | Pyrazolopyrimidine JAK inhibitor compounds and methods |
Non-Patent Citations (2)
Title |
---|
Ruthenium-Catalyzed Cycloadditon of Nitrile Oxides and Alkynes:Practical Synthesis of Isoxazoles;Scott Grecian,等;《Angew.Chem.Int.Ed.》;20080922;第47卷(第43期);第8285-8287页 * |
来氟米特3-甲基异构体的制备及结构确证;奚小金,等;《化工时刊》;20080930;第22卷(第9期);第23-25页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103539753A (en) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102659726B (en) | Method for synthesis of dronedarone | |
CN104130258A (en) | Conversion method for dimers | |
CN112062712A (en) | Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride | |
CN102584705B (en) | Preparation method of 3-hydroxy-substituted pyrazol | |
CN102408385B (en) | Preparation method of 2-substituent-2H-1,2,3-triazole derivative | |
CN103694204B (en) | 1,2,4-trisubstituent furan compound and preparation method thereof | |
CN111423394A (en) | Synthesis method of 1,3, 4-oxadiazole heterocyclic compound | |
CN103539753B (en) | A kind of synthetic method of the isoxazole carboxylic acid of 3 substitution 4 | |
CN108373468B (en) | Preparation method of N-2-pyridine-5-pyrimidine methylamine | |
CN110283066A (en) | It is a kind of how smooth intermediate 2-(3,5- bis- (trifluoromethyl) phenyl of appropriate pyrrole) -2 Methylpropionic acid synthetic method | |
WO2016045416A1 (en) | Intermediate for use in synthesizing paroxetine, preparation method for the intermediate, and uses thereof | |
KR101810515B1 (en) | 4-benzyl-1-phenethyl-piperazine-2,6-dione preparation method, and intermediate and preparation method thereof | |
CN103772189B (en) | Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A | |
EP4140993A1 (en) | Efficient preparation method for tedizolid intermediate, and intermediate | |
CN104086456A (en) | Synthesis method of sartanbiphenyl | |
CN104529736A (en) | Preparation method of p-fluorophenyl butanone | |
CN106279132B (en) | 2, 4-imidazoline diketone heterocyclic derivative and preparation method and application thereof | |
CN104817548B (en) | A kind of organic molecule that Selective recognition is visualized to lithium hydroxide, sodium hydroxide, potassium hydroxide | |
CN107200729B (en) | Preparation method of 4- (2-methoxyphenyl) -5- (2-pyridyl) -3-aminoisoxazole | |
CN101891731A (en) | Method for synthesizing olopatatadine E-configurational isomer | |
CN108069918B (en) | Method for preparing 3-difluoromethyl isoxazole compound by one-pot method | |
CN108129367B (en) | Construction method for constructing chiral sulfinyl imine alpha-site chiral quaternary carbon, product and application thereof | |
WO2021020998A1 (en) | Method for producing roxadustat | |
CN117069711A (en) | Preparation method of benzoxazine-4-one derivative | |
CN105503853A (en) | Synthetic method of cefdinir activated thioester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI YAOMING KANGDE NEW MEDICINE DEVELOPMENT C Free format text: FORMER OWNER: SHANGHAI YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. WUHAN YAOMING KANGDE NEW DRUGS DEVELOPMENT CO., LTD. SHANGHAI STA PHARMACEUTICAL R + D CO., LTD. Effective date: 20141222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141222 Address after: 300457 No. 111 Huang Hai Road, TEDA Development Zone, Tianjin, Tanggu Applicant after: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Wuhan AppTec New Drug Development Co., Ltd. Address before: 300457 No. 111 Huang Hai Road, TEDA Development Zone, Tianjin, Tanggu Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. Applicant before: Shanghai STA Pharmaceutical R & D Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170522 Address after: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Address before: 300457 No. 111 Huang Hai Road, TEDA Development Zone, Tianjin, Tanggu Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200122 Address after: No. 699, South Huashi Road, Qidong Economic Development Zone, Nantong City, Jiangsu Province Patentee after: Nantong yaomingkant Pharmaceutical Technology Co., Ltd Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Patentee before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. |